View in EDS

5-Lipoxygenase-Activating Protein Inhibitors: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103).

Saved in:

Bibliographic Details
Title:	5-Lipoxygenase-Activating Protein Inhibitors: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103).
Authors:	John H. Hutchinson¹, Yiwei Li¹, Jeannie M. Arruda¹, Christopher Baccei¹, Gretchen Bain¹, Charles Chapman¹, Lucia Correa¹, Janice Darlington¹, Christopher D. King¹, Catherine Lee¹, Dan Lorrain¹, Pat Prodanovich¹, Haojing Rong¹, Angelina Santini¹, Nicholas Stock¹, Peppi Prasit¹, Jilly F. Evans¹
Source:	Journal of Medicinal Chemistry. Oct2009, Vol. 52 Issue 19, p5803-5815. 13p.
Database:	Academic Search Ultimate

Description
ISSN:	00222623
DOI:	10.1021/jm900945d